Searched for
VENKATESWARLU JASTI
PE Advent completes acquisition of Suven Pharma, appoints new Board and management teamPrivate equity firm Advent International has completed its majority acquisition of Indian contract development and manufacturing organisati...- Buy Suven Pharmaceuticals, target price Rs 520: Nuvama Wealth brokerageBroken 3-month consolidation range on the higher side affirming a strong base formation at 470 levels.
- Advent International buys Suven Pharma for Rs 6,313 croreAdvent will also launch an open offer for an additional 26% of the company, a listed contract research and manufacturing services (CRAMS) b...
- Suven Pharma falls 2% as Advent picks majority stake in the companyPost the completion of this acquisition, Advent intends to explore the merger of its portfolio company, Cohance Lifesciences with Suven, to...
- Suven Pharma MD on selling 50% stake to Advent, open offer & running the business“It is business as usual and it will be done by us. They are taking this to increase their bandwidth and also for us to develop the revenue...
- Advent pips Blackstone, set to buy Suven Pharma for Rs 6300 crMarket capitalisation of Suven Pharma, as on Friday, was ₹12,682.43 crore. ET was the first to report on the sale on December 23. Advent is...
- Advent pips Blackstone, set to buy Suven Pharma for Rs 6300 crAnnouncement expected as early as Monday morning. Open offer if fully subscribed to could make it a $1 bn deal
- Advent closes in on Suven Pharma buyoutPromoters Venkateswarlu Jasti and his family split Suven Life Sciences in FY20, turning the CRAMS business into a separately listed company...
- Suven Pharma boss sells residential property in Hyderabad’s plush Jubilee Hills for Rs 34.75 croreThe 9405 sq. ft property was purchased by Bhagwati Devi Baldwa, a director with a Hyderabad-based firm. The residential property was earlie...
- Blackstone, CVC Capital & Warburg Pincus in race for Suven PharmaNew investor to become controlling shareholder in likely Rs 6,500 cr deal; due diligence begins
- Buy Suven Life Sciences, price target Rs 326: Kunal BothraThe analyst suggested a stoploss at Rs 305.
- Buy Suven Life Sciences, target Rs 312: Kunal BothraBuy Suven Life Sciences Ltd. at a price target of Rs 312.0 and a stoploss at Rs 280 from entry point.
- Buy Suven Life Sciences, target Rs 250: Jay ThakkarBuy Suven Life Sciences at a price target of Rs 250 and a stop loss at Rs 202 from entry point.
- Buy Suven Life Sciences, target Rs 205 : Rajesh Palviya, Axis SecuritiesBuy Suven Life Sciences at a price target of Rs 205 and a stop loss at Rs 166 from entry point.
- Buy Suven Life Sciences, target Rs 210: Manas JaiswalBuy Suven Life Sciences Ltd. at a price target of Rs 210.0 and a stop loss at Rs 189.0 from entry point
Load More
